INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 501.00 / 169.82K |
Day Range | - - - |
52 Wk Range | 6.50 - 14.74 |
Market Cap | $152.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 13.03% |
Days to Cover | 23.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Other companies in INmune Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
There is no analysis for INmune Bio.
INmune Bio has a consensus price target of $12.33.
The stock price for INmune Bio (NASDAQ: INMB) is $7.72 last updated Today at July 9, 2024 at 7:10 AM EDT.
There are no upcoming dividends for INmune Bio.
INmune Bio’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for INmune Bio.
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.